Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bicycle Therapeutics (BCYC) Receivables - Net (2019 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Receivables - Net for 7 consecutive years, with $136000.0 as the latest value for Q1 2025.

  • For Q1 2025, Receivables - Net changed N/A year-over-year to $136000.0; the TTM value through Mar 2025 reached $136000.0, changed N/A, while the annual FY2022 figure was $2.0 million, 104.5% up from the prior year.
  • Receivables - Net hit $136000.0 in Q1 2025 for Bicycle Therapeutics, down from $233000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $50.0 million in Q1 2023 and bottomed at $136000.0 in Q1 2025.
  • Average Receivables - Net over 5 years is $12.4 million, with a median of $2.0 million recorded in 2022.
  • Year-over-year, Receivables - Net soared 2073.91% in 2023 and then crashed 99.48% in 2024.
  • Bicycle Therapeutics' Receivables - Net stood at $1.0 million in 2021, then soared by 104.5% to $2.0 million in 2022, then skyrocketed by 2104.89% to $45.1 million in 2023, then plummeted by 99.48% to $233000.0 in 2024, then tumbled by 41.63% to $136000.0 in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $136000.0, $233000.0, and $45.1 million for Q1 2025, Q2 2024, and Q2 2023 respectively.